NSRI
CBPO

New Silk Road Investment’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

New Silk Road Investment’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-189,395
Closed -$17.5M – 10
2017
Q3 		$17.5M Buy
+189,395
New +$18.2M 9.13% 3

Other funds holding CBPO

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CGI
Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

New Silk Road Investment's CBPO Position: Q4 2017 in Review

New Silk Road Investment sold out of China Biologic Products Holdings, Inc. (CBPO) in Q4 2017, closing a stake of 189,395 shares — an estimated $17.5M sold.

New Silk Road Investment first reported a position in CBPO in Q3 2017 and held it in 1 quarter. The position peaked at $17.5M in Q3 2017. 93 funds tracked by Wall St. Rank hold CBPO as of Q4 2017.

  • New Silk Road Investment reported no remaining China Biologic Products Holdings, Inc. position as of Q4 2017 after selling out during the quarter.
  • New Silk Road Investment sold 189,395 China Biologic Products Holdings, Inc. shares in Q4 2017, an estimated $17.5M.
  • New Silk Road Investment first reported a position in China Biologic Products Holdings, Inc. in Q3 2017 and held it in 1 quarter.
  • New Silk Road Investment's China Biologic Products Holdings, Inc. position peaked at $17.5M in Q3 2017.
  • 93 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q4 2017.

Based on New Silk Road Investment's 13F filing for Q4 2017, filed 10 Jan 2018.